Education
About Us
Working with TipRanks
Follow Us
Justin B. Klee Insider Profile
4 Followers
Justin B. Klee, Co- CEO, Director at Amylyx Pharmaceuticals Inc, holds 3.36M shares in Amylyx Pharmaceuticals Inc (Ticker: AMLX). Most recently, Justin B. Klee Sold 21,490 shares of Amylyx Pharmaceuticals Inc on Apr 02, 2025 for an estimated value of $74.36K.
Justin B. Klee Amylyx Pharmaceuticals Inc (AMLX)Co- CEO, Director
Amylyx Pharmaceuticals Inc (AMLX)
Co- CEO, Director
Ranked #101,581 out of 103,606 Corporate Insiders
Profitable Transactions
2 out of 7 Profitable Transactions
Average Return
-177.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
Co- CEO, Director
Roles that Justin B. Klee holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 07, 2024 - Mar 07, 2025
Return:+79.50%
The most profitable trade made by Justin B. Klee
Justin B. Klee's Trading History
List of latest transactions for each holding click on a transaction to see Justin B. Klee's performance on stock
You May Also Like
Justin B. Klee insider profile FAQ
What is the percentage of profitable transactions made by Justin B. Klee?
The percentage of profitable transactions made by Justin B. Klee is 29%.
What is the average return per transaction made by Justin B. Klee?
The average return per transaction made by Justin B. Klee is -177.60%.
What stocks does Justin B. Klee hold?
Justin B. Klee holds: AMLX stocks.
What was Justin B. Klee’s latest transaction?
Justin B. Klee latest transaction was an Informative Sell of $74.36K.
What was Justin B. Klee's most profitable transaction?
Justin B. Klee’s most profitable transaction was an Informative Sell of AMLX stock on March 7, 2024. The return on the trade was 79.50%.
What is Justin B. Klee's role in Amylyx Pharmaceuticals Inc?
Justin B. Klee's role in Amylyx Pharmaceuticals Inc is Co- CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.